(Press-News.org) PORTLAND, Ore. - Oregon Health & Science University's development of a new gene therapy method to prevent certain inherited diseases has reached a significant milestone. Researchers at the university's Oregon National Primate Research Center and the OHSU Department of Obstetrics & Gynecology have successfully demonstrated their procedure in human cells. It's believed that this research, along with other efforts, will pave the way for future clinical trials in human subjects.
The research results are online Wednesday, Oct. 24, in the highly respected journal Nature. Dr. Mitalipov also will present the results of his research at the American Society for Reproductive Medicine Conference in San Diego Oct. 24'.
The OHSU gene therapy method was initially devised through research in nonhuman primates led by Shoukhrat Mitalipov, Ph.D., associate scientist in the Division of Reproductive & Developmental Sciences at ONPRC, Oregon Stem Cell Center and OHSU School of Medicine departments of Obstetrics and Gynecology and Molecular and Medical Genetics.
The procedure was specifically developed to prevent diseases related to gene defects in the cell mitochondria. Mitalipov's previous work was published in the August 2009 edition of Nature. In the current study, Mitalipov, in collaboration with Paula Amato, M.D., associate professor of obstetrics and gynecology in the OHSU Center for Women's Health, demonstrated efficacy of this therapy in human gametes and embryos.
"Cell mitochondria contain genetic material just like the cell nucleus and these genes are passed from mother to infant," explained Mitalipov. "When certain mutations in mitochondrial DNA are present, a child can be born with severe conditions, including diabetes, deafness, eye disorders, gastrointestinal disorders, heart disease, dementia and several other neurological diseases. Because mitochondrial-based genetic diseases are passed from one generation to the next, the risk of disease is often quite clear. The goal of this research is to develop a therapy to prevent transmission of these disease-causing gene mutations."
To conduct this research, Mitalipov and his colleagues obtained 106 human egg cells from study volunteers recruited through OHSU's Division of Fertility and Reproductive Endocrinology. The researchers then used a method developed in previous nonhuman primate studies, to transfer the nucleus from one cell to another. In effect, the researchers "swapped out" the cell cytoplasm, which contains the mitochondria. The egg cells were then fertilized to determine whether the transfer was a success and whether the cells developed normally. Upon inspection, it was demonstrated that it was possible to successfully replace mitochondrial DNA using this method.
"Using this process, we have shown that mutated DNA from the mitochondria can be replaced with healthy copies in human cells," explained Mitalipov. "While the human cells in our study only allowed to develop to the embryonic stem cell stage, this research shows that this gene therapy method may well be a viable alternative for preventing devastating diseases passed from mother to infant."
The current Nature paper also expanded upon the previously reported nonhuman primate work by demonstrating that the method was possible using frozen egg cells. Mitochondria were replaced in a frozen/thawed monkey egg cell, resulting in the birth of a healthy baby monkey named Chrysta.
The second portion of the study, which was completed at ONPRC, is also considered an important achievement because egg cells only remain viable for a short period of time after they are harvested from a donor. Therefore, for this therapy to be a viable option in the clinic, preservation through freezing likely is necessary so that both the donor cell and a mother's cell are viable at the time of the procedure.
While this form of therapy has yet to be approved in the United States, the United Kingdom is seriously considering its use for treating human patients at risk for mitochondria-based disease. It's believed that this most recent breakthrough, combined with earlier animal studies, will help inform that decision-making process.
Because the research involved the use of human egg cells and there are restrictions to the use of federal funding for some work in human egg cells, private funding was obtained to accomplish the work.
In addition, researchers consulted with ethicists and other experts within OHSU's Institutional Review Board and the OHSU Stem Cell Research Oversight Committee (OSCRO) prior to embarking on this research. The OSCRO reviews research involving human embryonic stem cells at OHSU to ensure that all federal and state regulations governing the conduct of stem cell research are met and that all human embryonic stem cell research is conducted in accordance with the general principles expressed in the National Academies' Guidelines for Human Embryonic Stem Cell Research. The OHSU IRB reviews biomedical and behavioral research that involves humans in order to protect the rights and welfare of the research subjects.
###
The human oocyte/embryo research was supported by grants from the OHSU Center for Women's Health Circle of Giving and additional private funds from OHSU as well as the Leducq Foundation and the OHSU Vice President for Research office. The nonhuman primate study was supported by grants from the National Institutes of Health.
About OHSU
Oregon Health & Science University is a nationally prominent research university and Oregon's only public academic health center. It serves patients throughout the region with a Level 1 trauma center and nationally recognized Doernbecher Children's Hospital. OHSU operates dental, medical, nursing and pharmacy schools that rank high both in research funding and in meeting the university's social mission. OHSU's Knight Cancer Institute helped pioneer personalized medicine through a discovery that identified how to shut down cells that enable cancer to grow without harming healthy ones. OHSU Brain Institute scientists are nationally recognized for discoveries that have led to a better understanding of Alzheimer's disease and new treatments for Parkinson's disease, multiple sclerosis and stroke. OHSU's Casey Eye Institute is a global leader in ophthalmic imaging, and in clinical trials related to eye disease.
About ONPRC
The ONPRC is a registered research institution, inspected regularly by the United States Department of Agriculture. It operates in compliance with the Animal Welfare Act and has an assurance of regulatory compliance on file with the National Institutes of Health. The ONPRC also participates in the voluntary accreditation program overseen by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).
MULTIMEDIA
Graphic that illustrates the procedure
http://www.ohsu.edu/news/media/images/MitochondriaGeneTherapy.jpg
Research Q & A
http://www.ohsu.edu/xd/about/news_events/news/2012/genetherapyfaq.cfm
Downloadable B-Roll of the procedure in human egg cells - (https://vimeo.com/51311557) - Password: mito33
Downloadable sound bites with Dr. Mitalipov
(https://vimeo.com/51301039) - Password: mito33
Mitalipov comments with b-roll for Web embedding
(https://vimeo.com/51310387) - Password: mito33
Downloadable B-roll from the Mitalipov lab.
(https://vimeo.com/51311306) - Password: mito33
Downloadable B-roll of Chrysta (monkey)
(https://vimeo.com/51644486) - Password: mito33
Photos of Dr. Mitalipov, monkey and cell manipulation
(http://www.flickr.com/photos/ohsunews/sets/72157631799935640/)
OHSU researchers test new gene therapy method in human cells... and it works
2012-10-25
ELSE PRESS RELEASES FROM THIS DATE:
Archer fish hunt insects with water jet 6 times stronger than their muscular power
2012-10-25
Archer fish knock their insect prey out of overhanging vegetation with a jet of water several times more powerful than the fish's muscles. New research now shows that the fish generate this power externally using water dynamics rather than with any specialized internal organs. The research, published Oct. 24 in the open access journal PLOS ONE by Alberto Vailati and colleagues from the University of Milan, provides the first explanation for how archer fish can generate such powerful jets to capture their prey.
Other animals like chameleons and salamanders store energy ...
Older adults worse at distinguishing between lifted weights than younger counterparts
2012-10-25
As we grow older, we are less capable of correctly estimating differences in the weights of objects we lift, according to a study published Oct. 24 in the open access journal PLOS ONE by Jessica Holmin and Farley Norman from North Dakota State University and Western Kentucky University, respectively.
Previous studies have shown that aging is frequently associated with a decrease in muscle mass and consequently strength, making it more difficult to lift objects. As a result, older adults often perceive weights they lift as being heavier than they actually are. In the current ...
Satellite images tell tales of changing biodiversity
2012-10-25
Analysis of texture differences in satellite images may be an effective way to monitor changes in vegetation, soil and water patterns over time, with potential implications for measuring biodiversity as well, according to new research published Oct. 24 by Matteo Convertino from the University of Florida and colleagues in the open access journal PLOS ONE.
The authors designed statistical models to estimate two aspects of biodiversity in satellite images: the number of species in a given region, or 'species richness', and the rate at which species entered or were removed ...
Gene mutation identifies colorectal cancer patients who live longer with aspirin therapy
2012-10-25
BOSTON—Aspirin therapy can extend the life of colorectal cancer patients whose tumors carry a mutation in a key gene, but has no effect on patients who lack the mutation, Dana-Farber Cancer Institute scientists report in the Oct. 25 issue of the New England Journal of Medicine.
In a study involving more than 900 patients with colorectal cancer, the researchers found that, for patients whose tumors harbored a mutation in the gene PIK3CA, aspirin use produced a sharp jump in survival: five years after diagnosis, 97 percent of those taking aspirin were still alive, compared ...
Electronic nose could be used to detect sleep apnoea
2012-10-25
An electronic nose, used to detect the presence of molecules in the breath of a patient, could be used to diagnose obstructive sleep apnoea.
A new study, published online today ahead of print (25 October 2012) in the European Respiratory Journal, could make the diagnosis of the condition quick and inexpensive compared to current methods.
The gold standard used to identify sleep apnoea is an overnight sleep test. This is technically demanding, time-consuming and cost-intensive.
Electronic nose devices have been shown to distinguish between a number of diseases; ...
Live cables explain enigmatic electric currents
2012-10-25
This press release is available in German.
Researchers at Aarhus University, Denmark, made a sensational discovery almost three years ago when they measured electric currents in the seabed. It was unclear as to what was conducting the current, but the researchers imagined the electric currents might run between different bacteria via a joint external wiring network.The researchers have now solved the mystery. It turns out that the whole process takes place inside bacteria that are one centimetre long. They make up a kind of live electric cable that no one had ever imagined ...
Feeling hot, hot, hot
2012-10-25
We're not used to thinking of ourselves as animals. But as Jason Samson sees it, climate is as important in shaping the distribution and movement of humans as it is in other animals. The McGill-trained ecologist and fellow researchers have been using modeling techniques similar to those used to define the ecological niche for plant and animal species to explore the correlation between climate patterns and population growth in the contiguous United States between 1900-2000. And what they discovered was a pronounced population shift away from areas within the U.S. with cool ...
Astronomers report that dark matter 'halos' may contain stars, disprove other theories
2012-10-25
Could it be that dark matter "halos" — the huge, invisible cocoons of mass that envelop entire galaxies and account for most of the matter in the universe — aren't completely dark after all but contain a small number of stars? Astronomers from UCLA, UC Irvine and elsewhere make a case for that in the Oct. 25 issue of the journal Nature.
Astronomers have long disagreed about why they see more light in the universe than it seems they should — that is, why the infrared light they observe exceeds the amount of light emitted from known galaxies.
When looking at the cosmos, ...
Flycatchers' genomes explain how 1 species became 2
2012-10-25
Just how new species are established is still one of the most central questions in biology. In an article in the leading scientific journal Nature, researchers at Uppsala University in Sweden describe how they mapped the genomes of the European pied flycatcher and the collared flycatcher and found that it is disparate chromosome structures rather than separate adaptations in individual genes that underlies the separation of the species.
"We were surprised that such a large part of the genome was nearly identical in the two species," says Hans Ellegren, professor of evolutionary ...
Parkinson's breakthough could slow disease progression
2012-10-25
CHICAGO --- In an early-stage breakthrough, a team of Northwestern University scientists has developed a new family of compounds that could slow the progression of Parkinson's disease.
Parkinson's, the second most common neurodegenerative disease, is caused by the death of dopamine neurons, resulting in tremors, rigidity and difficulty moving. Current treatments target the symptoms but do not slow the progression of the disease.
The new compounds were developed by Richard B. Silverman, the John Evans Professor of Chemistry at the Weinberg College of Arts and Sciences ...